
GLP-1 Risks Explained Simply
You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and
Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993
For visual reference only; actual product may vary
US Name:
Biktarvy
Alternative Names:
Biktarvy
Active Ingredients:
Bictegravir, Emtrictabine, Tenofovir
Brand Manufacturer:
Gilead SI
Manufacturer Location:
Ireland
Click here to view Product Insert
Click here to view Product Insert
For visual reference only; actual product may vary
Biktarvy is a once-daily prescription antiretroviral medication used for treating Human Immunodeficiency Virus 1 (HIV-1). It combines three active ingredients into a single tablet to effectively suppress the virus and manage the condition in adults, helping prevent the virus from weakening the immune system.
| Biktarvy Brand | 50-200-25 30 Tablets |
-
|
Our price: $1,150.00 |
|
| Biktarvy Brand | 50-200-25 30 Tablets |
-
|
Our price: $714.00 |
Biktarvy is a complete, single-tablet prescription medication used to treat Human Immunodeficiency Virus-1 (HIV-1), the virus that causes AIDS. It functions as a full antiretroviral therapy (HAART) regimen, meaning most patients do not need to take any other HIV medications alongside it. The tablet contains a combination of three active ingredients: bictegravir (50mg), emtricitabine (200mg), and tenofovir alafenamide (25mg), which work together to control the virus.
Biktarvy works by combining three active ingredients to block enzymes that the HIV-1 virus needs to multiply, thereby reducing the amount of the virus in your body (viral load). Bictegravir is an integrase strand transfer inhibitor (INSTI) that stops the virus from inserting its DNA into the DNA of your healthy immune cells. Emtricitabine and tenofovir alafenamide are nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), which prevent the virus from converting its RNA into DNA, another crucial step for its replication. This combined attack helps maintain a low viral load and allows the immune system to recover.
Biktarvy is intended for adults and children weighing at least 14 kg who are infected with HIV-1. It is often prescribed for patients who are starting HIV-1 treatment for the first time (treatment-naive). It can also be used to replace a current antiretroviral regimen for individuals who have an undetectable viral load (less than 50 copies/mL) for at least three months, have been on a stable regimen, and have no history of treatment failure or known resistance to Biktarvy’s components.
The standard dosage for Biktarvy is one tablet taken orally once per day, with or without food. It is crucial to take the tablet at approximately the same time each day to maintain consistent levels of the medication in your blood. If you miss a dose but remember within 18 hours of the usual time, take it as soon as you remember. If more than 18 hours have passed, skip the missed dose and take the next one at your regular time. Do not take two doses at once to make up for a missed one. Do not stop taking Biktarvy without consulting your healthcare provider, as this can cause the virus to multiply rapidly.
Like all medications, Biktarvy can cause side effects, with the most common being diarrhea, nausea, and headache. Many users experience mild to moderate side effects that may lessen over time. However, it’s important to be aware of all potential reactions. The most common side effects include:
Biktarvy carries a boxed warning for the potential worsening of Hepatitis B infection. Patients with both HIV and Hepatitis B should be closely monitored by their doctor after stopping the medication. More serious, though less common, side effects can include kidney problems, liver issues, and lactic acidosis. Contact your doctor immediately if you experience unusual muscle pain, weakness, stomach pain with nausea, or yellowing of the skin or eyes.
IsraelPharm provides a reliable and cost-effective way to access Biktarvy and other essential medications from the convenience of your home. We are staffed by licensed pharmacists who ensure every prescription is reviewed for safety and accuracy. By sourcing medications from a regulated global supply chain, we can offer competitive prices without compromising on quality or authenticity. We are committed to patient privacy, providing discreet packaging and secure, direct-to-doorstep delivery, making managing your health simpler and more affordable.
This medication may cause side effects. Consult your doctor for medical advice about side effects. The most common side effects of Biktarvy include:
Serious side effects can occur, including new or worsening kidney problems, severe liver problems, and changes in your immune system (Immune Reconstitution Syndrome). This drug has a boxed warning for post-treatment acute exacerbation of hepatitis B. Do not stop taking Biktarvy without first talking to your healthcare provider.
Biktarvy is a prescription medication indicated for the treatment of Human Immunodeficiency Virus-1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg. It is a complete regimen for patients new to HIV treatment or as a replacement for a current stable antiretroviral regimen for those with a suppressed viral load.
If you realize you missed a dose within 18 hours of your usual time, take it as soon as you remember. If more than 18 hours have passed, skip the missed dose and just take your next dose at the regular time. Do not double up on doses to make up for the missed one. Maintaining a consistent schedule is very important for the drug's effectiveness.
Certain medications should not be taken with Biktarvy, as they can cause serious interactions. These include dofetilide, rifampin, and the herbal supplement St. John's wort. Antacids containing aluminum or magnesium should be taken at least 2 hours before or 6 hours after your Biktarvy dose. Always inform your doctor of all medications, supplements, and vitamins you are taking.
Biktarvy begins to work immediately after you start taking it, reducing the ability of HIV to replicate. While you may not feel it working, blood tests will show a decrease in your viral load. For many people, the viral load can become undetectable within 8 to 24 weeks of starting treatment. This is why regular follow-ups with your doctor are essential.
No, Biktarvy is not a cure for HIV. It is an antiretroviral treatment that suppresses the virus, keeping your viral load low and preventing the virus from damaging your immune system. Taking it every day as prescribed can help you live a long, healthy life and reduces the risk of transmitting HIV to others, but it does not eliminate the virus from your body.
No, Biktarvy is a complete HIV treatment regimen in a single tablet. It contains three different active ingredients that work together to control the virus. You should not take Biktarvy with other antiretroviral medicines unless specifically instructed to do so by your healthcare provider. This simplifies the treatment process and reduces the number of pills you need to take each day.
Moderate alcohol consumption is generally not expected to interact with Biktarvy. However, excessive alcohol use can strain the liver, and Biktarvy can also affect the liver in some people. It's also important to consider that alcohol can impair your judgment and ability to stick to your daily medication schedule. It is best to discuss your alcohol use with your doctor.
Biktarvy should be stored at room temperature, below 86°F (30°C), in its original bottle with the cap tightly closed. Keep it away from excess moisture and heat. Do not store it in a bathroom or other damp environment, as this can affect the medication's stability. As with all prescription drugs, keep it safely out of reach of children and pets.
You should never stop taking Biktarvy without consulting your doctor. Stopping treatment can lead to a rapid increase in your viral load (viral rebound) and may cause the virus to become resistant to the medication. For patients who have Hepatitis B, stopping Biktarvy can cause a severe flare-up of the hepatitis. Always talk to your healthcare provider first if you are considering stopping treatment.
Weight gain has been observed in some people who take HIV medications, including those in the same class as Biktarvy (integrase inhibitors). The reasons are not fully understood and can be complex, sometimes related to the body's recovery after starting effective treatment. If you experience significant or concerning weight gain after starting Biktarvy, discuss it with your healthcare provider to explore potential causes and management strategies.
Biktarvy contains tenofovir alafenamide (TAF), a form of tenofovir designed to have less impact on the kidneys than an older version. However, all HIV medications in this class have the potential to affect kidney function. Your doctor will monitor your kidney health through regular blood and urine tests before and during your treatment with Biktarvy to ensure it remains safe for you.
If you are pregnant or planning to become pregnant, you should discuss this with your doctor immediately. There is a pregnancy registry that monitors the health of mothers and babies exposed to Biktarvy during pregnancy. Your doctor can help you weigh the benefits of continuing treatment to control your HIV against any potential risks and ensure both you and your baby remain healthy.
Biktarvy is a complete, single-tablet regimen for treating HIV, containing three active ingredients. Truvada, on the other hand, contains two active ingredients (emtricitabine and an older form of tenofovir) and must be combined with at least one other antiretroviral drug to be a complete treatment. Biktarvy uses a newer form of tenofovir (TAF) which has a better safety profile for kidneys and bones compared to Truvada's TDF.
Biktarvy is generally well-tolerated for long-term use. The most common side effects like nausea and headache often resolve early in treatment. Long-term monitoring focuses on kidney and liver function, as well as bone density, as these can be affected over time by this class of medication. Maintaining regular appointments with your healthcare provider is the best way to monitor for and manage any potential long-term effects.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and

People whose weight is higher than what is considered healthy for their height are described as having excessive body mass, clinically defined as being overweight or obese. Both of these can increase a person’s risk

The old saying “the devil is in the detail” has never been more applicable than it is right now. Multiple patients are discovering that what they regarded as straightforward access to prescribed medication once a


